IMPACT OF TYPE 2 DIABETES-ASSOCIATED DIPEPTIDYL PEPTIDASE-4 (DPP-4) MUTATIONS ON LIGAND BINDING AND ENZYME ACTIVITY MODULATED BY NATURAL COMPOUNDS
Open Access
- 31 December 2025
- journal article
- Published by Mugla Sitki Kocman University in Mugla Journal of Science and Technology
- Vol. 11 (2) , 169-178
Abstract
Type 2 diabetes is a chronic metabolic disorder marked by insulin resistance and β-cell dysfunction. DPP-4 inhibitors help regulate glucose by prolonging the effects of GLP-1 and GIP. This study examined how three mutations in the DPP-4 enzyme, V266I, G189E, and S437T, affect binding affinity with natural ligands (caffeic acid, proanthocyanidin, and palmatine) using in silico methods. The amino acid sequence of DPP-4 was obtained from UniProt, and mutation effects were assessed via HOPE. 3D models were generated through Swiss-Model and validated with SAVES v6.1, showing high structural accuracy (e.g., ERRAT: 97.3%). Molecular docking with AutoDock Vina showed strong binding of palmatine and Caffeic Acid Phenethyl Ester (CAPE) to wild-type DPP-4 (–7.6 kcal/mol). However, all three mutations led to reduced binding affinity, with scores ranging from –5.3 to –6.9 kcal/mol. The G189E mutation, in particular, caused a notable drop in binding energy due to the disruption of electrostatic and hydrophobic interactions. These structural changes suggest that such mutations may decrease the efficacy of DPP-4 inhibitors. Therefore, they represent critical factors to consider in drug design targeting this enzyme.Keywords
This publication has 24 references indexed in Scilit:
- Diabetes mellitus, the fastest growing global public health concern: Early detection should be focusedHealth Science Reports, 2024
- A genomic mutational constraint map using variation in 76,156 human genomesNature, 2023
- PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNANucleic Acids Research, 2021
- Proanthocyanidins in grape seeds: An updated review of their health benefits and potential uses in the food industryJournal of Functional Foods, 2020
- Unique binding mode of Evogliptin with human dipeptidyl peptidase IVBiochemical and Biophysical Research Communications, 2017
- Molecular mechanisms of incretin hormone secretionCurrent Opinion in Pharmacology, 2013
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?Diabetologia, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individualsActa Diabetologica, 2008
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004